87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience. (December 2022) - Zhang, S.H.; Cartwright, E.; Mullings, S.; Ferro Lopez, L.F.; Cunningham, D.; Chau, I.; Starling, N.; Popat, S.; O'Brien, M.E.R.; Bhosle, J.; Minchom, A.R.; Davidson, M.; et al.